312 related articles for article (PubMed ID: 30126839)
1. A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.
Calderon BM; Conn GL
J Biol Chem; 2018 Oct; 293(41):16115-16124. PubMed ID: 30126839
[TBL] [Abstract][Full Text] [Related]
2. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
3. RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase.
Schwartz SL; Conn GL
Wiley Interdiscip Rev RNA; 2019 Jul; 10(4):e1534. PubMed ID: 30989826
[TBL] [Abstract][Full Text] [Related]
4. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
5. A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.
Vachon VK; Calderon BM; Conn GL
Nucleic Acids Res; 2015 Jan; 43(1):544-52. PubMed ID: 25477390
[TBL] [Abstract][Full Text] [Related]
6. Role of helical structure and dynamics in oligoadenylate synthetase 1 (OAS1) mismatch tolerance and activation by short dsRNAs.
Schwartz SL; Dey D; Tanquary J; Bair CR; Lowen AC; Conn GL
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017296
[TBL] [Abstract][Full Text] [Related]
7. Length dependent activation of OAS proteins by dsRNA.
Wang Y; Holleufer A; Gad HH; Hartmann R
Cytokine; 2020 Feb; 126():154867. PubMed ID: 31629990
[TBL] [Abstract][Full Text] [Related]
8. The Activation Mechanism of 2'-5'-Oligoadenylate Synthetase Gives New Insights Into OAS/cGAS Triggers of Innate Immunity.
Lohöfener J; Steinke N; Kay-Fedorov P; Baruch P; Nikulin A; Tishchenko S; Manstein DJ; Fedorov R
Structure; 2015 May; 23(5):851-862. PubMed ID: 25892109
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
Sánchez-Tacuba L; Rojas M; Arias CF; López S
J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
[TBL] [Abstract][Full Text] [Related]
10. New insights into the role of RNase L in innate immunity.
Chakrabarti A; Jha BK; Silverman RH
J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
[TBL] [Abstract][Full Text] [Related]
11. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
[TBL] [Abstract][Full Text] [Related]
12. OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.
Banerjee S; Gusho E; Gaughan C; Dong B; Gu X; Holvey-Bates E; Talukdar M; Li Y; Weiss SR; Sicheri F; Saunthararajah Y; Stark GR; Silverman RH
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5071-5076. PubMed ID: 30814222
[TBL] [Abstract][Full Text] [Related]
13. Origin and development of oligoadenylate synthetase immune system.
Hu J; Wang X; Xing Y; Rong E; Ning M; Smith J; Huang Y
BMC Evol Biol; 2018 Dec; 18(1):201. PubMed ID: 30587119
[TBL] [Abstract][Full Text] [Related]
14. Functional evolution of the OAS1 viral sensor: Insights from old world primates.
Fish I; Boissinot S
Infect Genet Evol; 2016 Oct; 44():341-350. PubMed ID: 27393659
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
[TBL] [Abstract][Full Text] [Related]
16. The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.
Elkhateeb E; Tag-El-Din-Hassan HT; Sasaki N; Torigoe D; Morimatsu M; Agui T
Infect Genet Evol; 2016 Nov; 45():393-401. PubMed ID: 27663720
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation.
Dai J; Yi G; Philip AA; Patton JT
mBio; 2022 Dec; 13(6):e0299522. PubMed ID: 36413023
[TBL] [Abstract][Full Text] [Related]
18. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
[TBL] [Abstract][Full Text] [Related]
19. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.
Lee WB; Choi WY; Lee DH; Shim H; Kim-Ha J; Kim YJ
BMB Rep; 2019 Feb; 52(2):133-138. PubMed ID: 30078389
[TBL] [Abstract][Full Text] [Related]
20. The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.
Kwon YC; Kang JI; Hwang SB; Ahn BY
FEBS Lett; 2013 Jan; 587(2):156-64. PubMed ID: 23196181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
